Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Metadata
Title
Radiofrequency catheter septal ablation for HOCM in childhood
by M. Emmel, N. Sreeram, J. V. deGiovanni, K. Brockmeier; Z Kardiol 94:699–703 (2005)
Author
A. A. Schmaltz, MD
Publication date
01-03-2006
Publisher
Steinkopff-Verlag
Published in
Clinical Research in Cardiology / Issue 3/2006
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-006-0360-4

Other articles of this Issue 3/2006

Clinical Research in Cardiology 3/2006 Go to the issue

Erratum

Gender differences in the metabolic syndrome and their role for cardiovascular disease

CASE REPORT

Bundle branch reentrant tachycardia in a patient with a calcified bicuspid aortic valve and normal ventricular function

CASE REPORT

Interventional embolization of a giant pulmonary arteriovenous malformation with right–left–shunt associated with hereditary hemorrhagic telangiectasia

ORIGINAL PAPER

A hybrid approach for quantification of aortic valve stenosis using cardiac magnetic resonance imaging and echocardiography:

CLINICAL PICTURES

Wolff–Parkinson–White syndrome associated with persistent left superior vena cava

ORIGINAL PAPER

Atrial fibrillation—

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits